Latest News in the pharma Industry

Policy & Regulation

FDA Expands Approved Use of Imbruvica for Chronic Lymphocytic Leukemia

FDA Expands Approved Use of Imbruvica for Chronic Lymphocytic Leukemia

30 Jul 2014

Read more 
Salix and Pharming Announce FDA Approval of Ruconest

Salix and Pharming Announce FDA Approval of Ruconest

18 Jul 2014

Read more 
New Report Shows UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard

New Report Shows UK Cancer Patients Face Increasing Coverage Restrictions Due to Centralized Cost-Effectiveness Standard

14 Jul 2014

Read more 
The Active Pharmaceutical Ingredient Committee (APIC) Publishes a Draft “How to do” Document on GDP

The Active Pharmaceutical Ingredient Committee (APIC) Publishes a Draft “How to do” Document on GDP

9 Jul 2014

Read more 
Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza  and Sunvepra Dual Regimen

Japan Approves First All-Oral, Interferon- and Ribavirin-Free Hepatitis C Treatment, Daklinza and Sunvepra Dual Regimen

7 Jul 2014

Read more 
FDA Outlines Expectations for Human Drug Compounders, Including Registered Outsourcing Facilities

FDA Outlines Expectations for Human Drug Compounders, Including Registered Outsourcing Facilities

2 Jul 2014

Read more 
FDA Approves Mannkind's Afrezza - a Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

FDA Approves Mannkind's Afrezza - a Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

30 Jun 2014

Read more 
Shire’s ADHD Medication Patents Found to Be Infringed and Valid by US District Court

Shire’s ADHD Medication Patents Found to Be Infringed and Valid by US District Court

25 Jun 2014

Read more 
FDA Approves Biogen Idec's Eloctate, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children

FDA Approves Biogen Idec's Eloctate, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children

10 Jun 2014

Read more 
SMC Makes Negative Recommendation for Abraxane, Treatment for Metastatic Pancreatic Cancer

SMC Makes Negative Recommendation for Abraxane, Treatment for Metastatic Pancreatic Cancer

10 Jun 2014

Read more 
European Medicines Agency Accepts Accelerate?d Marketing Authorisat?ion Applicatio?n for Nintedanib? in IPF

European Medicines Agency Accepts Accelerate?d Marketing Authorisat?ion Applicatio?n for Nintedanib? in IPF

5 Jun 2014

Read more 
AstraZeneca’s Novel Antibiotic Candidate AZD0914 Given Fast Track Status by US FDA

AstraZeneca’s Novel Antibiotic Candidate AZD0914 Given Fast Track Status by US FDA

3 Jun 2014

Read more